The case centers on the pharmaceutical company Eli Lilly.
But it’s not about whether the company is liable for alleged price gouging. It’s about the Democratic attorney general’s ability to investigate those allegations.
Lower courts have ruled she does not have that authority because that’s in the purview of other agencies.
Nessel would like the Supreme Court to overturn those rulings and clear a path for her to seek investigative subpoenas.
The court has not set a date for arguments, which would focus on the nuanced but critical question of whether to take the case or simply let the lower court rulings stand.
Eli Lilly said in a statement that lower courts got it right. Also that Nessel has ignored the company’s efforts to lower costs and cap insulin prices.
